|CH2000 Cardiac Diagnostic System|
The CH200 system is a state-of-the-art stress testing platform that includes Cambridge Heart’s proprietary Microvolt T-Wave Alternans (MTWA) option, the only Medicare-reimbursable MTWA test on the market.
Microvolt T-Wave Alternans (MTWA) enhances stress testing by incorporating a non-invasive, clinically-proven, reimbursable test that can help identify patients at risk for Sudden Cardiac Arrest (SCA).
This comprehensive solution enables you to assess both ischemic and arrhythmic risk, allowing you to determine the best overall risk management strategy for your patients.
With the CH2000, Cambridge Heart offers you:
To order in the U.S., contact Cambridge Heart Customer Service at:
For ordering information outside the U.S., contact one of our International Distributors.